BRTX
BioRestorative Therapies Inc
NASDAQ: BRTX · HEALTHCARE · BIOTECHNOLOGY
$0.23
+11.60% today
Updated 2026-04-30
Market cap
$5.86M
P/E ratio
—
P/S ratio
16.28x
EPS (TTM)
$-1.58
Dividend yield
—
52W range
$0 – $2
Volume
10.4M
BioRestorative Therapies Inc (BRTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $15589.00 | $1680.00 | $415996.00 | $628915.00 | $36355.00 | $81000.00 | $111000.00 | $130000.00 | $77000.00 | $46000.00 | $119800.00 | $145800.00 | $401000.00 | $359700.00 |
| Revenue growth (YoY) | — | — | — | — | -89.2% | +24661.7% | +51.2% | -94.2% | +122.8% | +37.0% | +17.1% | -40.8% | -40.3% | +160.4% | +21.7% | +175.0% | -10.3% |
| Cost of revenue | — | — | — | $1307.00 | $208.00 | $213834.00 | $261504.00 | $102.00 | $259260.00 | $0.00 | — | — | $205205.00 | $120544.00 | $165735.00 | $28072.00 | $23844.00 |
| Gross profit | — | — | — | $14282.00 | $1472.00 | $202162.00 | $367411.00 | $36253.00 | $-178260.00 | $111000.00 | — | $77000.00 | $46000.00 | $119800.00 | $145800.00 | $372928.00 | $335856.00 |
| Gross margin | — | — | — | 91.6% | 87.6% | 48.6% | 58.4% | 99.7% | -220.1% | 100.0% | 0.0% | 100.0% | 100.0% | 100.0% | 100.0% | 93.0% | 93.4% |
| R&D | — | $11620.00 | $12000.00 | $416180.00 | $1.59M | $1.43M | $2.11M | $2.88M | $2.15M | $1.51M | $1.72M | $876829.00 | $729058.00 | $3.51M | $4.03M | $5.35M | $10.09M |
| SG&A | $348000.00 | $1.93M | $3.44M | $5.04M | $3.04M | $3.57M | $5.26M | $4.86M | $6.24M | $5.89M | $6.52M | $1.92M | $25.47M | $15.58M | $11.33M | $6.58M | $5.89M |
| Operating income | — | $-2.07M | $-3.55M | $-5.57M | $-4.75M | $-4.92M | $-7.17M | $-7.80M | $-8.37M | $-7.65M | $-8.43M | $-2.75M | $-26.31M | $-18.97M | $-15.22M | $-11.56M | $-15.65M |
| Operating margin | — | — | — | -35746.1% | -282873.2% | -1183.3% | -1140.1% | -21447.6% | -10338.6% | -6889.8% | -6486.2% | -3574.1% | -57191.0% | -15838.1% | -10439.5% | -2881.6% | -4350.1% |
| EBITDA | — | $-1.85M | $-3.38M | $-5.85M | $-4.65M | $-4.83M | $-7.11M | $-7.61M | $-8.10M | $-9.06M | $-9.29M | $-9.48M | $-26.22M | $-18.74M | $-14.97M | $-11.37M | $-15.44M |
| EBITDA margin | — | — | — | -37555.4% | -276634.5% | -1160.1% | -1130.0% | -20943.3% | -9997.6% | -8158.2% | -7147.3% | -12312.4% | -56997.3% | -15645.2% | -10268.7% | -2834.4% | -4291.7% |
| EBIT | — | $-1.90M | $-3.47M | $-5.94M | $-4.75M | $-4.92M | $-7.32M | $-7.87M | $-8.36M | $-9.30M | $-9.51M | $-9.63M | $-26.31M | $-18.86M | $-15.14M | $-11.56M | $-15.65M |
| Interest expense | $0.00 | $24155.00 | $260011.00 | $591813.00 | $371281.00 | $285275.00 | $603026.00 | $763944.00 | $1.09M | $3.22M | $5.14M | $1.64M | $1.82M | $11650.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | — | $-2.26M | $-4.07M | $-6.54M | $-5.75M | $-5.59M | $-7.92M | $-8.64M | $-9.44M | $-12.52M | $-14.65M | $-11.27M | $-44.30M | $-13.22M | $-10.42M | $-8.98M | $-14.24M |
| Net income growth (YoY) | — | — | -80.0% | -60.5% | +12.0% | +2.8% | -41.8% | -9.0% | -9.4% | -32.5% | -17.0% | +23.0% | -293.0% | +70.2% | +21.2% | +13.8% | -58.6% |
| Profit margin | — | — | — | -41931.6% | -342333.0% | -1343.2% | -1259.9% | -23755.4% | -11660.1% | -11277.3% | -11267.6% | -14639.9% | -96311.5% | -11037.0% | -7145.2% | -2239.2% | -3959.4% |